|
Indication |
For active immunization against smallpox disease for persons determined to be at high risk for smallpox infection |
|
Proprietary Name |
ACAM2000 |
|
Manufacturer |
sanofi pasteur |
|
Viability |
Live attenuated |
|
Approved Ages |
1 year and older |
|
Dose |
A droplet (0.0025 mL) of reconstituted vaccine is picked up with a bifurcated needle by dipping needle into ACAM2000 vial. A droplet of ACAM2000 is administered by the percutaneous route
(scarification) using 15 jabs of a bifurcated needle. ACAM2000 should not be injected by the intradermal, subcutaneous, intramuscular, or intravenous route. |
|
Route |
Percutaneous using bifurcated needle |
|
Dose form |
Powder for suspension |
|
Appearance |
Clear to slightly hazy, colorless to straw-colored |
|
Concentration |
1.0-5.0 x 108 plaque-forming units (PFU)/mL or 2.5-12.5 x 105 PFU/dose determined by plaque assay in Vero cells |
|
Preservatives |
Phenol 0.25% |
|
Adjuvant |
HEPES (pH 6.5-7.5), 6-8 mM
Human serum albumin USP, 2%
Sodium chloride USP, 0.5–0.7%
Mannitol USP, 5%
Neomycin, trace amounts
Polymyxin B, trace amounts |
|
Excipients |
Brilliant green diluent until the 1980’s. Since
2002 diluent no longer brilliant green |
|
Adjuvant |
|
|
Allergens |
|
|
Preservatives |
Skin of vaccinated bovine calves |
|
Media |
Skin of vaccinated bovine calves |
|
Packaging |
Vial and Diluent for 100 vaccinations |
|
Routine Storage |
2 to 8°
C
|
|
Package Insert data |
Sep 2009 |
|
updated
Feb 2013 |